Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances

por Mráziková, Lucia, Hojná, Silvie, Pačesová, Andrea, Hrubá, Lucie, Strnadová, Veronika, Neprašová, Barbora, Železná, Blanka, Kuneš, Jaroslav, Maletínská, Lenka
Publicado 2022

Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease

por Hojná, Silvie, Kotsaridou, Zoe, Vaňourková, Zdeňka, Rauchová, Hana, Behuliak, Michal, Kujal, Petr, Kadlecová, Michaela, Zicha, Josef, Vaněčková, Ivana
Publicado 2022

Renoprotection Provided by Additional Diuretic Treatment in Partially Nephrectomized Ren-2 Transgenic Rats Subjected to the Combined RAS and ET(A) Blockade

por Vaněčková, Ivana, Hojná, Silvie, Vernerová, Zdenka, Kadlecová, Michaela, Rauchová, Hana, Kompanowska-Jezierska, Elzbieta, Vaňourková, Zdeňka, Červenka, Luděk, Zicha, Josef
Publicado 2019

Lipidized PrRP Analog Exhibits Strong Anti-Obesity and Antidiabetic Properties in Old WKY Rats with Obesity and Glucose Intolerance

por Mráziková, Lucia, Hojná, Silvie, Vaculová, Petra, Strnad, Štěpán, Vrkoslav, Vladimír, Pelantová, Helena, Kuzma, Marek, Železná, Blanka, Kuneš, Jaroslav, Maletínská, Lenka
Publicado 2023

Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein

por Malínská, Hana, Hüttl, Martina, Marková, Irena, Miklánková, Denisa, Hojná, Silvie, Papoušek, František, Šilhavý, Jan, Mlejnek, Petr, Zicha, Josef, Hrdlička, Jaroslav, Pravenec, Michal, Vaněčková, Ivana
Publicado 2022